These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 11666109
1. Evaluating the benefits of increasing measles immunization rates. Zwanziger J, Szilagyi PG, Kaul P. Health Serv Res; 2001 Oct; 36(5):885-909. PubMed ID: 11666109 [Abstract] [Full Text] [Related]
2. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS. Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492 [Abstract] [Full Text] [Related]
3. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R. Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [Abstract] [Full Text] [Related]
4. Pertussis in adolescents and adults: should we vaccinate? Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [Abstract] [Full Text] [Related]
7. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM. J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102 [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Smith JC, Haddix AC, Teutsch SM, Glass RI. Pediatrics; 1995 Oct 01; 96(4 Pt 1):609-15. PubMed ID: 7567319 [Abstract] [Full Text] [Related]
9. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique. Griffiths UK, Hutton G, Das Dores Pascoal E. Health Policy Plan; 2005 Jan 01; 20(1):50-9. PubMed ID: 15689430 [Abstract] [Full Text] [Related]
10. Cost-utility analysis of cataract surgery in the second eye. Busbee BG, Brown MM, Brown GC, Sharma S. Ophthalmology; 2003 Dec 01; 110(12):2310-7. PubMed ID: 14644712 [Abstract] [Full Text] [Related]
11. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. Pediatrics; 2007 Jan 01; 119(1):e22-9. PubMed ID: 17200247 [Abstract] [Full Text] [Related]
12. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program. Babigumira JB, Levin A, Burgess C, Garrison LP, Bauch CT, Braka F, Mbabazi WB, Nabyonga JO, Simons E, Dabbagh A. J Infect Dis; 2011 Jul 01; 204 Suppl 1():S116-23. PubMed ID: 21666152 [Abstract] [Full Text] [Related]
13. Cost-effectiveness of supplementary immunization for measles in India. Dabral M. Indian Pediatr; 2009 Nov 01; 46(11):957-62. PubMed ID: 19578225 [Abstract] [Full Text] [Related]
14. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Pediatrics; 2007 Apr 01; 119(4):684-97. PubMed ID: 17403839 [Abstract] [Full Text] [Related]
15. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB. Ophthalmology; 2009 May 01; 116(5):823-32. PubMed ID: 19285730 [Abstract] [Full Text] [Related]
16. Could a federal program to promote influenza vaccination among elders be cost-effective? Patel MS, Davis MM. Prev Med; 2006 Mar 01; 42(3):240-6. PubMed ID: 16480761 [Abstract] [Full Text] [Related]
17. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Suresh GK, Clark RE. Pediatrics; 2004 Oct 01; 114(4):917-24. PubMed ID: 15466085 [Abstract] [Full Text] [Related]
18. The cost of Child Health Days: a case study of Ethiopia's Enhanced Outreach Strategy (EOS). Fiedler JL, Chuko T. Health Policy Plan; 2008 Jul 01; 23(4):222-33. PubMed ID: 18562457 [Abstract] [Full Text] [Related]
19. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus. Roe RH, Lass JH, Brown GC, Brown MM. Cornea; 2008 Oct 01; 27(9):1001-7. PubMed ID: 18812762 [Abstract] [Full Text] [Related]